These results provide support for the concept that stem-like CRC cells exhibit increased resistance to anti-EGFR therapies, and that the upregulation of c-MET orchestrated by YAP1 phosphorylation plays a significant role in this phenotype. The gene discussed is YAP1; the disease is colorectal carcinoma.